课题基金 / 基金详情

Immunoglobulins Delivered by AAV Vector for the Prevention of SIV Infection

Immunoglobulins Delivered by AAV Vector for the Prevention of SIV Infection
AAV 载体传递的免疫球蛋白用于预防 SIV 感染
批准号:
8860104
负责人:
Ronald C Desrosiers
金额:
$71.06万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-18 至 2016-12-09

项目摘要

项目成果

Ronald C Desrosiers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): AAV vector has recently been used to deliver single chain Fv immunoadhesin (scFVI) versions of rhesus monkey antibodies with neutralizing activity against SIV. High, persisting levels of scFVI were achieved in 6 of 9 rhesus monkeys and these six exhibited a sterilizing barrier against SIV challenge. Three of the nine monkeys developed antibody responses to the scFVI that they received and these three were not protected against SIV challenge. Two different approaches will be compared for AAV vector delivery of the authentic IgG version of these scFVIs. We will determine whether delivery of authentic IgG decreases the frequency with which anti-anti responses are observed. We will determine whether AAV vector can be used to deliver dimeric secretory IgA and whether secretory IgA provides a more effective barrier to SIV infection by the mucosal route. Finally, we will determine whether antibody-dependent cellular cytotoxicity is important for the protective effects of the IgG versions of 4L6 and 5L7. Results from these experiments in rhesus monkeys will inform and guide development of analogous vectors for the prevention of HIV-1 infection in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Limiting anti-drug antibodies
  • 批准号:
    10625286
  • 项目类别:
  • 资助金额:
    $40.3万
  • 财政年份:
    2020
  • 负责人:
    Ronald C Desrosiers
  • 依托单位:
Project 2: Limiting anti-drug antibodies
  • 批准号:
    10381478
  • 项目类别:
  • 资助金额:
    $31.62万
  • 财政年份:
    2020
  • 负责人:
    Ronald C Desrosiers
  • 依托单位:
Functional Role of O-Glycosylation of HIV-1
Functional Role of O-Glycosylation of HIV-1
海外基金